16
Jun
2026
Readline Biotech
Exhibitor at CPHI & PMEC China 2026 stand W3G02, Pharma Ingredients
About Us
Categories
-
Country/Region:China
-
On CPHI since:2019
-
Certificates:3
-
Employees:250 - 499
Company types
Primary activities
Contact info
-
-
-
B-6F, Wanhe Medical Park, Gaoxin C.1st Ave.,Shenzhen,China, GD, 518057, Shenzhen, Nanshan District, China
Event information
CPHI & PMEC China 2026
-
16 Jun 2026 - 18 Jun 2026
-
Shanghai New International Expo Center
-
Visit us at stand W3G02, Pharma Ingredients
Products Featured at CPHI & PMEC China 2026
-
Product Semaglutide (For R&D)
Semaglutide can also help the body increase sensitivity to insulin, improve satiety after meals, slow down gastric emptying, and suppress appetite, thereby playing a role in reducing body weight.
The semaglutide biosynthesized by Redlin has successfully passed the Drug Master File (DMF) filing of th... -
Product Peptide Sequence (9-37)
Redlin's semaglutide backbone successfully passed the US Food and Drug Administration (FDA) drug master file filing (DMF NUMBER ASSIGNED: 041076 -
Product Tirzepatide (For R&D) DMF 039791
Tirzepatide is a dual agonist of glucose-dependent insulinotropic peptide (GIP) receptor and glucagon-like peptide-1 (GLP-1) receptor.
-
Product tBuO-C20-Glu(AEEA-AEEA-OH)-OtBu
Used for Tirzepatide synthesis
Other name: (S)-22-(tert-Butoxycarbonyl)-45,45-dimethyl-10,19,24,43-tetraoxo-3,6,12,15,44-pentaoxa-9,18,23-triazahexatetracontanoic acid
The peptide has been registered with the US Food and Drug Administration (FDA) (DMF NUMBER ASSIGNED: 041461）
... -
Product Auto Injection Pen
Auto injection pens are usually equipped with prefilled syringes or cartridges that are driven by a spring system for quick and easy operation.
